Home » News » CROs/Service Providers » Omnicare’s CRO Division Holds Steady

Omnicare’s CRO Division Holds Steady

Friday, February 27, 2009

Omnicare reported its fourth quarter and year-end 2008 financial results, including the results for Omnicare’s subsidiary, contract research organization Omnicare Clinical Research.

Fourth quarter 2008 revenues for the company’s CRO business remained steady at $49.1 million, compared with $49 million in the same period last year. Adjusted operating profit for the fourth quarter 2008 was $5.2 million, compared with $3.6 million in Q4 2007.

Full-year revenues for 2008 were $203.3 million, up from $195.1 million in 2007. The CRO’s adjusted operating profit for the full year 2008 was $17.6 million, up from $13.1 million in 2007.

Omnicare Clinical Research provides phase I–IV contract research services, specializing in geriatrics-focused drug studies.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!